Granny's Meds - Medicine in the Bad Old
Days
Rosemary Jacobs © 1999
In The British Medical Journal on May 12, 1917 p. 624 there
is an article entitled "Herb Growing in the British
Empire", in which the author laments the fact that by
the time of the First World War England had become dependent
on the continent for synthetic chemicals & herbal medicines
that had been formerly grown and manufactured at home noting
that, "A medical friend who collected his own digitalis
and prepared his own tincture had told him that he found
that foxglove growing on a hot sandy bank protected by a
wood gave him the best results."
In 1924 Parke, Davis &Co., the drug company, published
the MANUAL OF THERAPY to promote, describe and explain the
use of their products to physicians. On p. 166 they state, "There
is hardly a drug in the Pharmacopoeia that is the occasion
of so much concern to the pharmacist and the physician as
digitalis. While it is universally recognized as the most
dependable heart tonic, it is at the same time an extremely
unstable drug in all forms."
Besides being unstable, the border line between the therapeutic
dose, the one which benefits the patient, was very close
to the toxic one, so much so in fact that the desired effects
sometimes appeared right along with the harmful ones. (Underhill
p.233).
With dye plants the control used to determine efficacy was
color. With botanical plants it was the pharmaceutical effect
produced in people and animals taking it. When a dye plant
was not standardized to the degree necessary to produce the
desired color, it could mean economic disaster. When a botanical
drug was not sufficiently standardized, it could mean death
to the patient.
In CHEMISTRY IN MEDICINE published in 1929, Robert A. Hatcher,
Ph.D., M.D. says, "Desperate conditions often justify
desperate remedies, and when a physician has a patient who
will surely die within a few hours if relief is not afforded
he may be compelled to adopt a measure that sometimes leads
to recovery and sometimes results fatally. There is probably
no physician who has been in general practice during many
years who has not found himself confronted by such a situation
more than once.
Formerly the physician whose patient suffered with cardiac
disease of such serious nature had no way of knowing the
activity of the digitalis that he was compelled to use. He
was forced, therefore to administer a dose that in his judgement
was best - sometimes it was just right, but often it was
too little or too much, and in either of these cases the
result was a tragedy." (p.501)
On p. 496 Hatcher notes that there were hundreds of thousands
of substances with therapeutic effects, but only about a
hundred of them were considered to be essential drugs for
treating the sick. He says that there were two reasons for
this. For many there were better agents available while others
had very bad side effects that made them dangerous. I like
to think of it as ingredients in a soup. Some add to the
flavor. Others subtract from it. The trick is knowing the
bad from the good and removing the former. That is a trick
for a chemist not a physician.
Hatcher continues, "Peruvian bark was used for the
cure of malaria during nearly two centuries before quinine
came into common use, and one may ask why we do not use it
today. It was a wonderful discovery for those who had no
better remedy against malaria that claimed millions of victims,
but we hear little today of the many failures that attended
its use." (p.498).
He goes on to say that no two specimens of Peruvian bark
contain the same amounts of the active ingredient quinine.
Therefore, it was impossible to know just how much of the
raw botanical a patient needed. As a result, the doctor usually
gave him about as much as he thought that he could stand
without being harmed. Sometimes the amount of quinine absorbed
was insufficient to cure the patient. Sometimes he absorbed
more than he required which could result in loss of hearing,
or worse yet, death. Hatcher and other scientists of the
day realized that such a hit-and-miss method of making drugs
had to be replaced with a more reliable one.
Active, beneficial ingredients had to be extracted from
natural substances, and active harmful ones had to be eliminated
or minimized to tolerable levels. Doses needed to be standardized
and delivered in a potency sufficient to effectively treat
the illness without seriously harming the patient since most
any substance potent enough to benefit a person also has
the potential of causing him harm. The pharmaceutical industry
developed to work out these problems, one baby step at a
time and one drug at a time since no two are exactly alike.
"Standardization" is the title of the first chapter
in P.D &Co.'s MANUAL OF THERAPY. It opens with, "One
of the most important developments in pharmaceutical practice
during the past fifty years, if indeed it may not be counted
the most important, has been the establishment of definite
standards for medicinal products on the basis of chemical
or physiological assays. This is so generally recognized
at the present time as a necessity that it is hard to realize
that it is less than thirty years since we encountered strong
opposition and violent criticism because of our introduction
of chemical assay methods as a means of standardizing fluid
extracts." (p.1).
In 1879 P. D .&Co. had introduced a standardized fluid
preparation of Ergot, "Liquor Ergotae Purificatus".
The assay used appeared crude in the light of the knowledge
that they had in 1924, but it had marked the beginning of
the scientific attempt to standardize drugs for potency.
Since the best research at the time, which was later disproved,
had indicated that sclerotic acid was probably the active
ingredient in ergot, the amount that was precipitated out
of the extract with lead acetate was used to give a crude
estimate of the amount contained in the preparation. It was
the first crude chemical assay that P.D.&Co. performed.
When chemical assays could not be developed, biological
ones had to be relied on. According to Blumgarten, "The
preparations of the members of the digitalis group are standardized
by their effect on animals under standard conditions because
the glucoside content of the crude plants is variable." (p.326)
On p. 322 Blumgarten notes that, "A cat unit is the
amount of digitalis which stops the beating of a cat's heart
when given intravenously."
On p. 333 he refers to the New and Nonofficial Preparation
called Digipuratum or digitan. "These are tablets made
from specially grown digitalis leaves from which many of
the inactive substances have been removed. They are not so
apt to cause nausea and vomiting. Each dose contains enough
digitoxin to kill a frog weighing 30.0 Gms. by stopping its
heart beat."
Just as the process of transferring a dye from a plant to
fiber was often difficult and tedious, so to was it sometimes
difficult to get a botanical into a patient in a way that
would effectively treat his illness. The May 12, 1917 issue
of The British Medical Journal has an article entitled, "The
Administration of Male Fern", a treatment for worms,
in which the author claims that the failure of the drug to
produce the desired effect was often due to the way in which
it was given. Taking it on an empty stomach was not enough.
The contents of the stomach had to be removed with a saline
aperient like Epsom salts or sodium sulphate along with 8
to 10 ounces of water. The fern had to be administered two
to three hours after the aperient had acted. The drug was
often vomited and for that reason it was necessary to combine
it with a carminative. Either a petroleum emulsion or milk
flavored with peppermint oil were recommended.
Since the remedy killed parasitic worms but did not cause
their expulsion, the patient then had to take a purgative
like castor oil to complete the treatment. (p.624)
Synthetic drugs, just like natural ones, had to be standardized
for purity and potency. In 1929 Arsphenamine (Salvarsan),
an arsenic preparation used to treat syphilis, was subjected
to both chemical and biological assays because toxic impurities
were easiest to determine through the use of animal tests.
(CHEMISTRY IN MEDICINE p.414) In reality a drug is a drug
is a drug. The origin is irrelevant. What counts is the way
it effects the person taking it. What counts is its safety,
efficacy, purity and potency.
Natural Dyes | Natural
Remedies | Bibliography